Dextech Medical

Dextech Medical Dividend

Dividend of Dextech Medical (DEX.SL) as of Nov 19, 2026.

Dividend

0.00SEK

Last updated:

How much dividend does Dextech Medical 2026 pay?

According to the latest status from November 2026, Dextech Medical paid a total of 0.00 SEK per share in dividends within the last 12 months. With the current Dextech Medical price of 9.76 SEK, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Historical Dextech Medical Dividends

Historical Dextech Medical Dividends
PaydateDividend

The Dextech Medical Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2019
0.00 SEK
Jan 1, 2020
0.00 SEK
Jan 1, 2021
0.00 SEK
Jan 1, 2022
0.00 SEK
Jan 1, 2023
0.00 SEK
Jan 1, 2024
0.00 SEK
Jan 1, 2025
0.00 SEK
Jan 1, 2026
0.00 SEK
The Dextech Medical Dividend history
YEARDividendYoY
0.00SEK—
0.00SEK—
0.00SEK—
0.00SEK—
0.00SEK—
0.00SEK—
0.00SEK—
0.00SEK—
0.00SEK—
0.00SEK—
0.00SEK—
0.00SEK—

Is the Dextech Medical Dividend Safe?

Dextech Medical has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Dividend Details

Understanding Dextech Medical's Dividend Distributions

Dextech Medical’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Dextech Medical's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Dextech Medical's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Dextech Medical’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Dextech Medical Stock analysis

What does Dextech Medical do? Dextech Medical AB develops drug candidates for urological oncology, focusing on prostate cancer and other conditions. The company utilizes its patented GuaDex technology platform to create modified carbohydrate molecules combined with active substances. Its portfolio includes OsteoDex for bone metastases in castration-resistant prostate cancer, SomaDex targeting acromegaly and neuroendocrine tumors, and CatDex for bladder cancer treatment. The company holds patents or patent applications for these three drug candidates. Dextech Medical AB's primary revenue streams come from licensing its technology and drug candidates to pharmaceutical partners. The company's GuaDex platform and its drug candidates, OsteoDex, SomaDex, and CatDex, are marketed to biopharmaceutical companies seeking innovative treatments for urological oncology and related diseases. The firm's focus on prostate cancer, bone metastases, and bladder cancer creates a targeted market for its products. The company's business model relies on developing and commercializing its drug candidates through partnerships with established pharmaceutical companies. With only three drug candidates in its portfolio, Dextech Medical AB targets specific therapeutic areas within urological oncology, leveraging its patented GuaDex platform to attract potential partners in the biopharmaceutical industry. Dextech Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dextech Medical stock

Dextech Medical paid dividends every year for the past 0 years.

Dextech Medical is assigned to the 'Health' sector.

The dividends of Dextech Medical are distributed in SEK.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

All Key Metrics — Dextech Medical